• Chromosome Breakage Study, Blood
  • Corynebacterium diphtheriae, Culture
  • Inflammatory Bowel Disease Serology Panel, Serum
  • PDGFRB/TEL Translocation (5;12) for Chronic Myelomonocytic Leukemia, FISH, Bone Marrow
  • Mycoplasma hominis, Molecular
  • HIV Drug Resistance Phenotyping Assay (Phenosense)
  • Epstein-Barr Virus (EBV), Molecular Detection, Quantitative PCR
  • Varicella Zoster Virus (VZV) Antibody, IgM, Serum
  • UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping
  • Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Gene Mutation Analysis (Translocation)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Medical Test

Clinical Utility
Access to Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis is restricted.